ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 66 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,511,580 | +4.6% | 609,673 | +10.7% | 0.00% | – |
| Q1 2024 | $4,313,116 | +67.5% | 550,845 | +8.7% | 0.00% | – |
| Q4 2023 | $2,574,757 | -16.8% | 506,842 | -3.1% | 0.00% | – |
| Q3 2023 | $3,096,113 | -13.4% | 522,992 | +8.6% | 0.00% | – |
| Q2 2023 | $3,574,236 | +293.9% | 481,703 | +401.7% | 0.00% | – |
| Q1 2023 | $907,342 | -51.8% | 96,015 | -45.6% | 0.00% | – |
| Q4 2022 | $1,881,110 | +238.9% | 176,630 | +134.8% | 0.00% | – |
| Q3 2022 | $555,000 | +53.3% | 75,215 | 0.0% | 0.00% | – |
| Q2 2022 | $362,000 | +12.4% | 75,215 | +19.4% | 0.00% | – |
| Q1 2022 | $322,000 | -4.5% | 63,015 | +12.5% | 0.00% | – |
| Q4 2021 | $337,000 | -31.2% | 55,992 | +1.3% | 0.00% | – |
| Q3 2021 | $490,000 | +12.1% | 55,292 | 0.0% | 0.00% | – |
| Q2 2021 | $437,000 | – | 55,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Interchange Capital Partners, LLC | 11,420 | $90,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 47,097 | $373,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $80,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 99,166 | $784,000 | 0.01% |
| EMFO, LLC | 1,666 | $13,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 34,333 | $272,000 | 0.01% |
| Hartford Financial Management Inc. | 598 | $5,000 | 0.00% |
| Global Financial Private Client, LLC | 266 | $2,059 | 0.00% |
| BLAIR WILLIAM & CO/IL | 51,466 | $407,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,808 | $30,000 | 0.00% |